Tamil Nadu Pregnancy and Heart Disease Registry (TNPHDR): design and methodology.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
29 Jan 2022
Historique:
received: 25 09 2021
accepted: 30 11 2021
entrez: 30 1 2022
pubmed: 31 1 2022
medline: 17 2 2022
Statut: epublish

Résumé

Cardiac disease in pregnancy is a major contributor to maternal mortality in high, middle and low-income countries. Availability of data on outcomes of pregnancy in women with heart disease is important for planning resources to reduce maternal mortality. Prospective data on outcomes and risk predictors of mortality in pregnant women with heart disease (PWWHD) from low- and middle-income countries are scarce. The Tamil Nadu Pregnancy and Heart Disease Registry (TNPHDR) is a prospective, multicentric and multidisciplinary registry of PWWHD from 29 participating sites including both public and private sectors, across the state of Tamil Nadu in India. The TNPHDR is aimed to provide data on incidence of maternal and fetal outcomes, adverse outcome predictors, applicability of the modified World Health Organization (mWHO) classification of maternal cardiovascular risk and the International risk scoring systems (ZAHARA and CARPREG I & II) in Indian population and identify possible gaps in the existing management of PWWHD. Pregnancy and heart teams will be formed in all participating sites. Baseline demographic, clinical, laboratory and imaging parameters, data on counselling received, antenatal triage and management, peripartum management and postpartum care will be collected from 2500 eligible participants as part of the TNPHDR. Participants will be followed up at one, three and six-months after delivery/termination of pregnancy to document study outcomes. Predictors of maternal and foetal outcome will be identified. The TNPHDR will be the first representative registry from low- and middle-income countries aimed at providing crucial information on pregnancy outcomes and risk predictors in PWWHD. The results of TNPHDR could help to formulate steps for improved care and to generate a customised and practical guideline for managing pregnancy in women with heart disease in limited resource settings. The TNPHDR is registered under Clinical Trials Registry-India ( CTRI/2020/01/022736 ).

Sections du résumé

BACKGROUND BACKGROUND
Cardiac disease in pregnancy is a major contributor to maternal mortality in high, middle and low-income countries. Availability of data on outcomes of pregnancy in women with heart disease is important for planning resources to reduce maternal mortality. Prospective data on outcomes and risk predictors of mortality in pregnant women with heart disease (PWWHD) from low- and middle-income countries are scarce.
METHODS METHODS
The Tamil Nadu Pregnancy and Heart Disease Registry (TNPHDR) is a prospective, multicentric and multidisciplinary registry of PWWHD from 29 participating sites including both public and private sectors, across the state of Tamil Nadu in India. The TNPHDR is aimed to provide data on incidence of maternal and fetal outcomes, adverse outcome predictors, applicability of the modified World Health Organization (mWHO) classification of maternal cardiovascular risk and the International risk scoring systems (ZAHARA and CARPREG I & II) in Indian population and identify possible gaps in the existing management of PWWHD. Pregnancy and heart teams will be formed in all participating sites. Baseline demographic, clinical, laboratory and imaging parameters, data on counselling received, antenatal triage and management, peripartum management and postpartum care will be collected from 2500 eligible participants as part of the TNPHDR. Participants will be followed up at one, three and six-months after delivery/termination of pregnancy to document study outcomes. Predictors of maternal and foetal outcome will be identified.
DISCUSSION CONCLUSIONS
The TNPHDR will be the first representative registry from low- and middle-income countries aimed at providing crucial information on pregnancy outcomes and risk predictors in PWWHD. The results of TNPHDR could help to formulate steps for improved care and to generate a customised and practical guideline for managing pregnancy in women with heart disease in limited resource settings.
TRIAL REGISTRATION BACKGROUND
The TNPHDR is registered under Clinical Trials Registry-India ( CTRI/2020/01/022736 ).

Identifiants

pubmed: 35093002
doi: 10.1186/s12884-021-04305-3
pii: 10.1186/s12884-021-04305-3
pmc: PMC8801092
doi:

Types de publication

Clinical Trial Protocol Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

80

Informations de copyright

© 2022. The Author(s).

Références

Obstet Gynecol. 2017 Aug;130(2):366-373
pubmed: 28697109
J Am Coll Cardiol. 2007 Jun 19;49(24):2303-11
pubmed: 17572244
Heart. 2006 Oct;92(10):1520-5
pubmed: 16973809
J Am Coll Cardiol. 2018 May 29;71(21):2419-2430
pubmed: 29793631
BJOG. 2014 Mar;121 Suppl 1:1-4
pubmed: 24641529
Eur Heart J. 2011 Dec;32(24):3147-97
pubmed: 21873418
Circulation. 2018 Feb 20;137(8):817-819
pubmed: 29459467
Circulation. 2001 Jul 31;104(5):515-21
pubmed: 11479246
BJOG. 2020 Jan;127(1):47-56
pubmed: 31512355
Cardiovasc J Afr. 2016 Mar-Apr;27(2):84-8
pubmed: 27213855
Eur Heart J. 2018 Sep 7;39(34):3165-3241
pubmed: 30165544
Trop Med Int Health. 2020 Jun;25(6):673-686
pubmed: 32133737
Acta Obstet Gynecol Scand. 2017 Sep;96(9):1112-1119
pubmed: 28542709
Obstet Gynecol. 2019 May;133(5):e320-e356
pubmed: 31022123
BMJ Open. 2018 Sep 28;8(9):e022755
pubmed: 30269070

Auteurs

Justin Paul Gnanaraj (JP)

Madras Medical College and Research Institute, Chennai, India. drjpheart@gmail.com.

S Anne Princy (SA)

Tamil Nadu Government Multi Super Speciality Hospital, Chennai, India.

Karen Sliwa-Hahnle (K)

Hatter Institute for Cardiovascular Research in Africa, Cape Town, South Africa.

Sowmya Sathyendra (S)

Christian Medical College, Vellore, India.

Nambirajan Jeyabalan (N)

Coimbatore Medical College, Coimbatore, India.

Ragothaman Sethumadhavan (R)

Government Medical College, Chengalpattu, India.

Selvarani G (S)

Government Medical College, Madurai, India.

N Sumathi (N)

Government Medical College, Madurai, India.

Vinotha S (V)

Government KAPV Medical College, Tiruchirappalli, India.

Pachaiappan P (P)

Government MKM Medical College, Salem, India.

Vimali Murali (V)

Madras Medical College and Research Institute, Chennai, India.

Shanthirani B (S)

Government Medical College, Theni, India.

Gomathi T (G)

Government Medical College, Tanjore, India.

Muthuprabha P (M)

Tirunelveli Medical College, Tirunelveli, India.

Panniyammakal Jeemon (P)

Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India.

E Elavarasi (E)

Madras Medical College and Research Institute, Chennai, India.

Rajarajeshwari R (R)

Government Medical College, Tanjore, India.

Vijaya S (V)

Madras Medical College and Research Institute, Chennai, India.

Kanmani K (K)

Madras Medical College and Research Institute, Chennai, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH